Home / News
-
-
Thermo Fisher will invest £5 million in Premaitha as a secured loan facility, of which the company will receive £3 million initially and the remainder as milestone payments over the next two years.2017-01-04View More
-
-
Illumina recently announced that it has launched a new whole genome sequencing service with BioMerieux that the two companies have developed together.2017-01-04View More
-
-
Canature announced in the morning of Dec. 21, Origincell Technology Group, its holding subsidiary signed a strategic cooperative agreement with NextCODE on Dec. 172017-01-04View More
-
-
? A cooperative agreement has been announced by Illumina and Novogene on 15th of this month to jointly develop the Next Generation of Sequencing platform2017-01-04View More
-
-
Google Ventures is going to start off 2016 with $2.4 billion under management. This year, life sciences and health remained the most active area of investment2017-01-04View More
-
-
The note shows, Marr Bio’s revenues from January to June in 2015 is £¤8.77 million, and net profit is £¤1.67 million.2017-01-04View More
-
-
Aspire Capital is a growth equity firm focused on making direct investments into public companies across various industries.2017-01-04View More
-
-
BGI recently announced that it has cooperated again with PacBio, which is the leader of the real-time single-molecule sequencing technology (SMRT), to purchase Asia’s first Sequel sequencing system.2017-01-04View More
-
-
The National Institutes of Health announced that it aims to award $2 million in grant funding in fiscal year 2017 for research around new biomarkers to diagnose active pulmonary tuberculosis (TB)2017-01-04View More
-
-
The National Institutes of Health has announced that it will allocate further funding to support the refinement of molecular cancer diagnostics2017-01-04View More
-
-
Recently, Shenzhen iCubio Biomedical Technology Co., Ltd. was approved to list on the new OTC market and public transfer.2017-01-04View More
-
-
After months of hard work, the ‘PrecisionFDA’ project proposed by the U.S. Food and Drug Administration in August 5 this year, was announced to be open for use in December 15.Users2017-01-04View More
-
-
Roche today announced that it has signed a definitive agreement to acquire Kapa Biosystems, Inc. (Kapa) a privately-held company headquartered in Wilmington, Massachusetts, US.2017-01-04View More
-
-
Recently, domestic diagnostic manufacturer General Biologicals Corporation (GBC) announced that they have signed a strategic cooperation agreement with the United States genetic testing company Veritas Genetics.2017-01-04View More
-
-
The statistics presented that the VC/PE financing scale in internet industry for the second quarter of 2015 was $3.789 billion reduced 50.36% on link relative ratio with 222 quantity of financing cases2017-01-04View More
-
-
Roche will partner with SQZ Biotech to develop a cell therapy platform that would empower a patient’s own immune cells to fight a broad range of cancers, in an immuno-oncology collaboration that could generate more than $500 million for SQZ.2017-01-04View More
-
-
Illumina has made a strategic investment in Desktop Genetics (DTG) to advance DTG’s DESKGEN genome-editing software platform, the companies said today. The value of the investment was not disclosed.2017-01-04View More
-
-
Roche will join Pieris Pharmaceuticals in an up-to-CHF 415 million ($409 million) cancer immunotherapy collaboration designed to develop new drug candidates based on Pieris’2017-01-04View More
-
-
Shortly after passing a critical inspection by the Centers for Medicare and Medicaid in which the agency looked at Theranos' lab instruments, the company raised $633 million from investors.2017-01-03View More
-
-
Great Basin Scientific today announced that it has signed a $20.5 million securities purchase agreement with institutional investors, which will provide the company with new funding for its ongoing operations.2017-01-03View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.